4//SEC Filing
ANDREEFF DANE 4
Accession 0001140361-23-055933
CIK 0001610853other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 8:30 AM ET
Size
16.0 KB
Accession
0001140361-23-055933
Insider Transaction Report
Form 4
ANDREEFF DANE
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2023-11-30$6.37/sh+641$4,083→ 10,633 total(indirect: See footnote) - Purchase
Common Stock
2023-12-01$6.45/sh+1,134$7,312→ 13,685 total(indirect: See footnote) - Purchase
Common Stock
2023-12-01$6.45/sh+229$1,477→ 2,832 total(indirect: See footnote) - Purchase
Common Stock
2023-11-30$6.37/sh+228$1,452→ 2,603 total(indirect: See footnote) - Purchase
Common Stock
2023-12-01$6.45/sh+643$4,146→ 11,276 total(indirect: See footnote) - Purchase
Common Stock
2023-11-30$6.37/sh+1,131$7,205→ 12,551 total(indirect: See footnote)
Holdings
- 30
Common Stock
- 599(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F2]The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F3]The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F4]The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
Documents
Issuer
HELIUS MEDICAL TECHNOLOGIES, INC.
CIK 0001610853
Entity typeother
Related Parties
1- filerCIK 0001201810
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 8:30 AM ET
- Size
- 16.0 KB